AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Sensus Healthcare Investors May Join Class Action Lawsuit with Schall Law Firm
ByAinvest
Sunday, Aug 24, 2025 5:36 pm ET1min read
Sensus Healthcare investors may join a lawsuit alleging false and misleading statements by the company. The lawsuit claims Sensus reported a significant miss on earnings and revenue decline due to lower sales to a large customer. The company's shares fell by 35.2% following the news. The Schall Law Firm is investigating the claims and encourages investors to contact them for free consultation.
Investors of Sensus Healthcare, Inc. (NASDAQ: SRTS) are advised to take note of a potential class action lawsuit alleging false and misleading statements by the company. The lawsuit claims that Sensus reported a significant miss on earnings and revenue decline due to lower sales to a large customer. The company's shares fell by 35.3% following the news, closing at $3.46 per share on August 8, 2025.The investigation into these allegations is being conducted by both the Portnoy Law Firm and Pomerantz LLP. The Portnoy Law Firm, based in Los Angeles, has encouraged investors who lost money on their investment to contact attorney Lesley F. Portnoy for a complimentary case evaluation. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is also investigating claims on behalf of Sensus investors. Danielle Peyton at Pomerantz LLP can be contacted for more information.
Sensus reported its financial results for the second quarter of 2025 on August 7, 2025. The company disclosed a GAAP earnings-per-share loss of $0.06, missing analyst estimates by $0.09, and revenue of $7.3 million, a decline of 20.7% year-over-year and below estimates by $2 million. Sensus attributed the revenue decline primarily to a reduction in units sold to a large customer, partially offset by growth in recurring revenue from Fair Deal Agreements.
Investors are advised to review their investment options carefully and consider seeking legal advice if they believe they have been affected by the alleged securities fraud. Both law firms have a history of recovering damages for investors in similar cases.
References:
[1] https://www.globenewswire.com/news-release/2025/08/21/3137595/0/en/Sensus-Healthcare-Inc-Investors-Company-Investigated-by-the-Portnoy-Law-Firm.html
[2] https://www.marketscreener.com/news/pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-sensus-healthcare-inc-srts-ce7c50dad08cf326
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet